These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12473248)

  • 1. Familial hypercholesterolaemia--screening is effective, but is it cost effective?
    Fox KF
    Eur Heart J; 2002 Dec; 23(24):1892-3. PubMed ID: 12473248
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Pears R; Griffin M; Futema M; Humphries SE
    Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolaemia: Cascade testing is tried and tested and cost effective.
    Hadfield GS; Humphries SE
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916820
    [No Abstract]   [Full Text] [Related]  

  • 4. Results from a family and DNA based active identification programme for familial hypercholesterolaemia.
    ten Asbroek AH; de Mheen PJ; Defesche JC; Kastelein JJ; Gunning-Schepers LJ
    J Epidemiol Community Health; 2001 Jul; 55(7):500-2. PubMed ID: 11413180
    [No Abstract]   [Full Text] [Related]  

  • 5. An initiative to extend testing for familial hypercholesterolaemia across the U.K.
    Nicholls M
    Eur Heart J; 2015 Oct; 36(39):2627-8. PubMed ID: 26756048
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands.
    Marang-van de Mheen PJ; ten Asbroek AH; Bonneux L; Bonsel GJ; Klazinga NS
    Eur Heart J; 2002 Dec; 23(24):1922-30. PubMed ID: 12473254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive.
    Kastelein JJ
    BMJ; 2000 Dec; 321(7275):1483-4. PubMed ID: 11118161
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attitude to genetic screening for familial hypercholesterolemia].
    Ose L; Vollebaek LE; Tonstad S
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1578-81. PubMed ID: 9615587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia.
    Farag TI
    J R Soc Med; 1988 Jun; 81(6):368. PubMed ID: 3404533
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolaemia: a look back, a look ahead.
    Burnett JR; Ravine D; van Bockxmeer FM; Watts GF
    Med J Aust; 2005 Jun; 182(11):552-3. PubMed ID: 15938678
    [No Abstract]   [Full Text] [Related]  

  • 19. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for familial hypercholesterolaemia in relatives.
    Tonstad S; Vollebaek LE; Ose L
    Lancet; 1995 Nov; 346(8987):1438. PubMed ID: 7475864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.